Skip to main content

Nasdaq News

UBS Upgrades Scotts Miracle-Gro to Buy from Neutral

3 weeks ago
Fintel reports that on October 15, 2026, UBS upgraded their outlook for Scotts Miracle-Gro (NYSE:SMG) (LSE:0L45) from Neutral to Buy. This rating action follows a prior action on July 30, 2026, when UBS maintained its Neutral rating on the stock.On October 14, 2026, the day befor

UBS Upgrades Regeneron Pharmaceuticals to Buy from Neutral

3 weeks ago
Fintel reports that on October 15, 2026, UBS upgraded their outlook for Regeneron Pharmaceuticals (NASDAQGS:REGN) (BIT:1REGN) from Neutral to Buy. On the day of the rating action, October 15, 2026, the stock closed at $796.34, following a close of $778.36 on the preceding day, Oc

Regeneron's Libtayo Wins EMA CHMP Support For Extended Dosing

3 weeks ago
(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending approval of an alternative dosing schedule for Libtayo (cemiplimab) acr
Checked
23 minutes 58 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article
Subscribe to Nasdaq News feed